NEU 2.99% $20.10 neuren pharmaceuticals limited

I find it annoying that the stock price is the subject of...

  1. 43 Posts.
    lightbulb Created with Sketch. 35
    I find it annoying that the stock price is the subject of continued paper cuts. Pre approval no ROW rights resulted in a reduction from 9 to 7. Post approval, no ROW rights resulted in a drop from 15 to the current price. ROW rights don’t equate to an aggregate $4.625 share price value and reduction, in my humble opinion, and yet it has and here we are. ROW rights announcement are unlikely to recover that loss. I find it hard to fathom that the stock price now is not at least double the pre approval price. Will I sell? Hell no. How does the company hire one or more market makers to eliminate death by paper cut?
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
(20min delay)
Last
$20.10
Change
-0.620(2.99%)
Mkt cap ! $2.569B
Open High Low Value Volume
$20.41 $20.45 $19.92 $5.947M 296.0K

Buyers (Bids)

No. Vol. Price($)
1 999 $20.10
 

Sellers (Offers)

Price($) Vol. No.
$20.19 10 1
View Market Depth
Last trade - 16.10pm 25/07/2024 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.